Abstract:Background & Objective: The objective of this study was to explore the risk factors for cognitive impairment in patients with cerebral small vessel disease (CSVD), and to construct a predictive model for cognitive impairment in CSVD patients, providing personalized diagnostic and treatment strategies for patients. Methods: Clinical data and blood indicators of CSVD patients admitted to the Department of Neurology at the Second Affiliated Hospital of Shandong First Medical University from February 2022 to February 2023 were collected. Additionally, these patients underwent cranial MRI examinations and completed neurological and psychological assessments, including the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). Based on the MoCA and MMSE results, the patients were divided into the cognitive impairment group and the normal cognitive group. Clinical data, blood indicators, and white matter lesion (WML) grades were compared between the two groups. Univariate logistic regression analysis was performed to identify the risk factors for cognitive impairment in CSVD patients. Using MoCA assessment results as the gold standard and several clinical indicators as independent variables, a logistic regression model was constructed. Predicted values were calculated based on this model, and a receiver operating characteristic (ROC) curve for the comprehensive diagnosis of multiple variables was plotted to evaluate the model’s accuracy. Results: A total of 134 CSVD patients were included, and cognitive impairment occurred in 98 cases, with an incidence rate of 73.13%, while 36 patients did not have cognitive impairment. Univariate logistic regression analysis of the collected variables identified eight factors: age, education level, hypertension, diabetes, cerebral hemorrhage, low-density lipoprotein cholesterol (LDL-C), hyperhomocysteine (HHCY), and WML grading. Multivariate logistic regression analysis identified age, LDL-C, and WML grading as the final predictive factors, establishing a combined diagnostic model to predict the probability of cognitive impairment in patients. The constructed ROC curve for the comprehensive diagnosis of multiple variables yielded an area under the curve of 0.870, indicating good accuracy. To facilitate clinical diagnosis, the combined diagnostic model was simplified into an L score calculation formula, with the optimal cutoff value of 5.223. When the L score is <5.223, the patient can be considered not having cognitive impairment, while an L score >5.223 indicates cognitive impairment, allowing for the prediction of the risk of cognitive impairment in patients. Conclusion: Age, education level, hypertension, diabetes, cerebral hemorrhage, LDL-C, HHCY, and WML grading are related risk factors for cognitive impairment in CSVD patients. Age, LDL-C, and WML grading are independent risk factors for cognitive impairment in CSVD patients. The clinical predictive model for cognitive impairment in cerebral small vessel disease, constructed using the final predictive factors, showed good performance and clinical utility. It facilitates individualized risk assessment for cognitive impairment in CSVD patients and allows for targeted follow-up observation for high-risk individuals.

Incidence and Risk Factors of Cognitive Impairment in Patients with Vascular Risk Factors

Aggregation of Vascular Risk Factors Modulates the Amplitude of Low-Frequency Fluctuation in Mild Cognitive Impairment Patients

A Risk Factor Analysis of Cognitive Impairment in Elderly Patients with Chronic Diseases in a Chinese Population

The Incidence and Burden of Risk Factors for Mild Cognitive Impairment in Older Rural Chinese Persons.

Vascular risk factors and cognitive impairment in patients with mild cognitive impairment

The clinical characteristics of vascular mild cognitive impairment

Risk Factors and Clinical Features of Mild Vascular Cognitive Impairment Due to Subcortical Small Vessel Disease

Influencing Factors of Vascular Cognitive Impairment Among Patients With Ischemic Stroke

The Screening of Vascular Risk Factors for Cognitive Dysfunction in Population with High Risk of Stroke

Analysis on Damage Features of Vascular Mild Cognitive Impairment

VasCog Screen test: sensitive in detecting cognitive impairment in patients who had a stroke or with heart failure

Preliminary Application of Montreal Cognitive Assessment in Vascular Cognitive Impairment

Logistic Regression Analysis on Self-Identification Screening System of Vascular Cognitive Impairment

The clinical characteristics of cognitive impairment in patients with vascular mild cognitive impairment: Neuropsychiatry and behavioral neurology/Mild cognitive impairment/Early symptomatic disease

P1-316: the clinical characteristics of cognitive impairment in patients with vascular mild cognitive impairment

The Montreal cognitive assessment: normative data from a large, population-based sample of Chinese healthy adults and validation for detecting vascular cognitive impairment

Risk factors of vascular cognitive impairment among Chinese population:Meta-analysis

Brief screening for mild cognitive impairment in subcortical ischemic vascular disease: a comparison study of the Montreal Cognitive Assessment with the Mini-Mental State Examination.

Correlation Factors Analysis of Vascular Cognitive Impairment and Its Subtypes of Acute Ischemic Stroke Patients

Exploration of a Comprehensive Index for Predicting Cognitive Impairment in Patients with Cerebral Small Vessel Disease and White Matter Lesions

Analysis of the related factors of old patients with mild cognitive impairment